BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fang Y, Wang J, Wang G, Zhou C, Wang P, Zhao S, Zhao S, Huang S, Su W, Jiang P, Chang A, Xiang R, Sun P. Inactivation of p38 MAPK contributes to stem cell-like properties of non-small cell lung cancer. Oncotarget 2017;8:26702-17. [PMID: 28460458 DOI: 10.18632/oncotarget.15804] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 de Miranda LBL, Lima K, Coelho-Silva JL, Traina F, Kobayashi SS, Machado-Neto JA. NT157 exerts antineoplastic activity by targeting JNK and AXL signaling in lung cancer cells. Sci Rep 2022;12:17092. [PMID: 36224313 DOI: 10.1038/s41598-022-21419-6] [Reference Citation Analysis]
2 Kudaravalli S, den Hollander P, Mani SA. Role of p38 MAP kinase in cancer stem cells and metastasis. Oncogene. [DOI: 10.1038/s41388-022-02329-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
3 Tang Y, Yang X, Wang Q, Huang H, Wang Q, Jiang M, Yuan C, Huang Y, Chen Y. ING4 Promotes Stemness Enrichment of Human Renal Cell Carcinoma Cells Through Inhibiting DUSP4 Expression to Activate the p38 MAPK/type I IFN-Stimulated Gene Signaling Pathway. Front Pharmacol 2022;13:845097. [DOI: 10.3389/fphar.2022.845097] [Reference Citation Analysis]
4 Kciuk M, Gielecińska A, Budzinska A, Mojzych M, Kontek R. Metastasis and MAPK Pathways. Int J Mol Sci 2022;23:3847. [PMID: 35409206 DOI: 10.3390/ijms23073847] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
5 Acosta-plasencia M, Castellano JJ, Taylor AM, He Y, Martínez D, Monzo M, Marrades RM, Navarro A. Patient-Derived Organoids as a Stem Cell Model to Study Lung Cancer. Interdisciplinary Cancer Research 2022. [DOI: 10.1007/16833_2022_78] [Reference Citation Analysis]
6 Xu W, Liu R, Dai Y, Hong S, Dong H, Wang H. The Role of p38γ in Cancer: From review to outlook. Int J Biol Sci 2021;17:4036-46. [PMID: 34671218 DOI: 10.7150/ijbs.63537] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
7 Momeny M, Arsiola T, Westermarck J. Cancer stem cell phosphatases. Biochem J 2021;478:2899-920. [PMID: 34319405 DOI: 10.1042/BCJ20210254] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Onuma S, Manabe A, Yoshino Y, Matsunaga T, Asai T, Ikari A. Upregulation of Chemoresistance by Mg2+ Deficiency through Elevation of ATP Binding Cassette Subfamily B Member 1 Expression in Human Lung Adenocarcinoma A549 Cells. Cells 2021;10:1179. [PMID: 34066059 DOI: 10.3390/cells10051179] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Bányai L, Trexler M, Kerekes K, Csuka O, Patthy L. Use of signals of positive and negative selection to distinguish cancer genes and passenger genes. Elife 2021;10:e59629. [PMID: 33427197 DOI: 10.7554/eLife.59629] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
10 Roy S, Roy S, Anuja K, Thakur S, Akhter Y, Padhi S, Banerjee B. p38 Mitogen-activated protein kinase modulates cisplatin resistance in Head and Neck Squamous Cell Carcinoma cells. Arch Oral Biol 2021;122:104981. [PMID: 33302041 DOI: 10.1016/j.archoralbio.2020.104981] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
11 Xiong J, Li Y, Tan X, Fu L. Small Heat Shock Proteins in Cancers: Functions and Therapeutic Potential for Cancer Therapy. Int J Mol Sci 2020;21:E6611. [PMID: 32927696 DOI: 10.3390/ijms21186611] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
12 Yao Y, Cui L, Ye J, Yang G, Lu G, Fang X, Zeng Z, Zhou J. Dioscin facilitates ROS-induced apoptosis via the p38-MAPK/HSP27-mediated pathways in lung squamous cell carcinoma. Int J Biol Sci 2020;16:2883-94. [PMID: 33061803 DOI: 10.7150/ijbs.45710] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
13 Chen S, Lu S, Yao Y, Chen J, Yang G, Tu L, Zhang Z, Zhang J, Chen L. Downregulation of hsa_circ_0007580 inhibits non-small cell lung cancer tumorigenesis by reducing miR-545-3p sponging. Aging (Albany NY) 2020;12:14329-40. [PMID: 32681720 DOI: 10.18632/aging.103472] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
14 Kabakov A, Yakimova A, Matchuk O. Molecular Chaperones in Cancer Stem Cells: Determinants of Stemness and Potential Targets for Antitumor Therapy. Cells 2020;9:E892. [PMID: 32268506 DOI: 10.3390/cells9040892] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 18.5] [Reference Citation Analysis]
15 Oklejas AE, Nör JE. Overcoming head and neck cancer stem cells. Improving the Therapeutic Ratio in Head and Neck Cancer 2020. [DOI: 10.1016/b978-0-12-817868-3.00007-x] [Reference Citation Analysis]
16 Wu VT, Kiriazov B, Koch KE, Gu VW, Beck AC, Borcherding N, Li T, Addo P, Wehrspan ZJ, Zhang W, Braun TA, Brown BJ, Band V, Band H, Kulak MV, Weigel RJ. A TFAP2C Gene Signature Is Predictive of Outcome in HER2-Positive Breast Cancer. Mol Cancer Res 2020;18:46-56. [PMID: 31619506 DOI: 10.1158/1541-7786.MCR-19-0359] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
17 Kim KW, Kim JY, Qiao J, Clark RA, Powers CM, Correa H, Chung DH. Dual-Targeting AKT2 and ERK in cancer stem-like cells in neuroblastoma. Oncotarget. 2019;10:5645-5659. [PMID: 31608140 DOI: 10.18632/oncotarget.27210] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
18 Bian Y, Teper Y, Mathews Griner LA, Aiken TJ, Shukla V, Guha R, Shinn P, Xin HW, Pflicke H, Powers AS, Li D, Jiang JK, Patel P, Rogers SA, Aubé J, Ferrer M, Thomas CJ, Rudloff U. Target Deconvolution of a Multikinase Inhibitor with Antimetastatic Properties Identifies TAOK3 as a Key Contributor to a Cancer Stem Cell-Like Phenotype. Mol Cancer Ther 2019;18:2097-110. [PMID: 31395684 DOI: 10.1158/1535-7163.MCT-18-1011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
19 Poe C, Youngblood C, Hodge K, Kemp K. Treatment of established TH2 cells with 4μ8c, an inhibitor of IRE1α, blocks IL-5 but not IL-4 secretion. BMC Immunol 2019;20:3. [PMID: 30630412 DOI: 10.1186/s12865-018-0283-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
20 Xu X, Zhang S, Hu Q, Song X, Pan W. Retracted : Effects of microRNA‐494 on proliferation, migration, invasion, and apoptosis of medulloblastoma cells by mediating c‐myc through the p38 MAPK signaling pathway. J Cell Biochem 2019;120:2594-606. [DOI: 10.1002/jcb.27559] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
21 Roy S, Roy S, Kar M, Padhi S, Saha A, Anuja K, Banerjee B. Role of p38 MAPK in disease relapse and therapeutic resistance by maintenance of cancer stem cells in head and neck squamous cell carcinoma. J Oral Pathol Med 2018;47:492-501. [PMID: 29575240 DOI: 10.1111/jop.12707] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
22 Casey SC, Baylot V, Felsher DW. The MYC oncogene is a global regulator of the immune response. Blood 2018;131:2007-15. [PMID: 29514782 DOI: 10.1182/blood-2017-11-742577] [Cited by in Crossref: 94] [Cited by in F6Publishing: 96] [Article Influence: 23.5] [Reference Citation Analysis]